Dr. Howard Smith Oncall

Vidcast:  https://www.instagram.com/p/CxLvX4cR6Ap/ Semaglutide, the current “it” drug for weight loss, that was initially approved for management of non-insulin requiring diabetes, type 2 diabetes, cuts and even eliminates the need for insulin injections by type 1 diabetics.  This small University of Buffalo study was just published in the New England Journal of Medicine. Endocrinologists there studied 10 recently diagnosed diabetes type 1 patients.  Each person was begun on injectable insulin both over the day and at mealtimes but was also given semaglutide.  Over a 90 day period during which the semaglutide dose was increased, all were able to eliminate insulin for meals.  Over 6 months, 7 of the 10 eliminated the need for any insulin. During the study, the mean HbA1c of the group fell from 11.7 to 5.7. Normal is less than 7 These incredible findings, if confirmed in a larger, randomized, double-blinded study, could revolutionize the management of so-called insulin-dependent diabetes.  Stay tuned. http